Bright Minds Biosciences (DRUG) Technical Analysis

As of 2026-10-26, DRUG last traded at 51.09 USD (-2.65% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: 49.06 USD support below, 55.78 USD resistance above. 14-day RSI is 55.1 (bullish).

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

Is DRUG in an uptrend or downtrend?

Bright Minds Biosciences is in a range — insufficient history for 200-DMA.

Last close51.09 USD (-2.65%)
20-day average51.643 USD
50-day average61.537 USD
200-day averagen/a

Key support and resistance levels for DRUG

Derived from swing pivots over the last 69 sessions:

LevelTypeStrengthTouches
55.78 USDResistanceMinor1
62.45 USDResistanceMinor1
78.85 USDResistanceMinor1
LevelTypeStrengthTouches
49.06 USDSupportMinor1
47.23 USDSupportMinor1

DRUG 52-week range, momentum and volatility

52-week high87 USD (41.3% below)
52-week low47.23 USD (8.2% above)
14-day RSI55.1 (Bullish)
14-day ATR4.011 USD (7.85% of price, High volatility)

Related research pages

More on DRUG

Frequently asked questions

Is Bright Minds Biosciences (DRUG) in an uptrend or downtrend?

As of 2026-10-26, DRUG is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 51.09 USD vs 50-day average 61.537 USD and 200-day average n/a.

What are the key support and resistance levels for DRUG?

Nearest support is around 49.06 USD (minor, 1 touch). Nearest resistance is around 55.78 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is DRUG's 52-week high and low?

Over the last 52 weeks, DRUG traded between 47.23 USD and 87 USD. It is currently 41.3% below its 52-week high.

Is DRUG overbought or oversold?

The 14-day RSI is 55.1 — in a neutral 30–70 range. Momentum reads as bullish.

How volatile is DRUG?

Its 14-day Average True Range is 4.011 (7.85% of price) — high volatility relative to price.